230 related articles for article (PubMed ID: 30679389)
1. The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.
D'Arcy BM; Swingle MR; Papke CM; Abney KA; Bouska ES; Prakash A; Honkanen RE
Mol Cancer Ther; 2019 Mar; 18(3):556-566. PubMed ID: 30679389
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
3. Active-site mutations impairing the catalytic function of the catalytic subunit of human protein phosphatase 2A permit baculovirus-mediated overexpression in insect cells.
Myles T; Schmidt K; Evans DR; Cron P; Hemmings BA
Biochem J; 2001 Jul; 357(Pt 1):225-32. PubMed ID: 11415453
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
Chattopadhyay D; Swingle MR; Salter EA; Wood E; D'Arcy B; Zivanov C; Abney K; Musiyenko A; Rusin SF; Kettenbach A; Yet L; Schroeder CE; Golden JE; Dunham WH; Gingras AC; Banerjee S; Forbes D; Wierzbicki A; Honkanen RE
Biochem Pharmacol; 2016 Jun; 109():14-26. PubMed ID: 27002182
[TBL] [Abstract][Full Text] [Related]
5. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.
Ho WS; Sizdahkhani S; Hao S; Song H; Seldomridge A; Tandle A; Maric D; Kramp T; Lu R; Heiss JD; Camphausen K; Gilbert MR; Zhuang Z; Park DM
Cancer Lett; 2018 Feb; 415():217-226. PubMed ID: 29199006
[TBL] [Abstract][Full Text] [Related]
6. Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit.
Bryant JC; Westphal RS; Wadzinski BE
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):241-6. PubMed ID: 10191253
[TBL] [Abstract][Full Text] [Related]
7. The Saccharomyces cerevisiae type 2A protein phosphatase Pph22p is biochemically different from mammalian PP2A.
Zabrocki P; Swiatek W; Sugajska E; Thevelein JM; Wera S; Zolnierowicz S
Eur J Biochem; 2002 Jul; 269(14):3372-82. PubMed ID: 12135475
[TBL] [Abstract][Full Text] [Related]
8. Purine nucleotide- and sugar phosphate-induced inhibition of the carboxyl methylation and catalysis of protein phosphatase-2A in insulin-secreting cells: protection by divalent cations.
Kowluru A; Metz SA
Biosci Rep; 1998 Aug; 18(4):171-86. PubMed ID: 9877231
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the enzymatic properties of protein phosphatase 2A catalytic subunit by the recombinant 65-kDa regulatory subunit PR65alpha.
Turowski P; Favre B; Campbell KS; Lamb NJ; Hemmings BA
Eur J Biochem; 1997 Aug; 248(1):200-8. PubMed ID: 9310379
[TBL] [Abstract][Full Text] [Related]
10. PP2A inhibition by LB-100 protects retinal pigment epithelium cells from UV radiation via activation of AMPK signaling.
Li XF; Li SY; Dai CM; Li JC; Huang DR; Wang JY
Biochem Biophys Res Commun; 2018 Nov; 506(1):73-80. PubMed ID: 30340831
[TBL] [Abstract][Full Text] [Related]
11. Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits.
Prickett TD; Brautigan DL
J Biol Chem; 2004 Sep; 279(37):38912-20. PubMed ID: 15252037
[TBL] [Abstract][Full Text] [Related]
12. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.
Hong CS; Ho W; Zhang C; Yang C; Elder JB; Zhuang Z
Cancer Biol Ther; 2015; 16(6):821-33. PubMed ID: 25897893
[TBL] [Abstract][Full Text] [Related]
13. LB-100 sensitizes hepatocellular carcinoma cells to the effects of sorafenib during hypoxia by activation of Smad3 phosphorylation.
Fu QH; Zhang Q; Zhang JY; Sun X; Lou Y; Li GG; Chen ZL; Bai XL; Liang TB
Tumour Biol; 2016 Jun; 37(6):7277-86. PubMed ID: 26666823
[TBL] [Abstract][Full Text] [Related]
14. Regulation by glucose and calcium of the carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting INS-1 cells.
Palanivel R; Veluthakal R; Kowluru A
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E1032-41. PubMed ID: 14970009
[TBL] [Abstract][Full Text] [Related]
15. Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial.
Chung V; Mansfield AS; Braiteh F; Richards D; Durivage H; Ungerleider RS; Johnson F; Kovach JS
Clin Cancer Res; 2017 Jul; 23(13):3277-3284. PubMed ID: 28039265
[No Abstract] [Full Text] [Related]
16. Carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting cells: evidence for functional consequences on enzyme activity and insulin secretion.
Kowluru A; Seavey SE; Rabaglia ME; Nesher R; Metz SA
Endocrinology; 1996 Jun; 137(6):2315-23. PubMed ID: 8641181
[TBL] [Abstract][Full Text] [Related]
17. Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells.
Teruya T; Simizu S; Kanoh N; Osada H
FEBS Lett; 2005 Apr; 579(11):2463-8. PubMed ID: 15848189
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.
Ho WS; Wang H; Maggio D; Kovach JS; Zhang Q; Song Q; Marincola FM; Heiss JD; Gilbert MR; Lu R; Zhuang Z
Nat Commun; 2018 May; 9(1):2126. PubMed ID: 29844427
[TBL] [Abstract][Full Text] [Related]
19. Anti-renal interstitial fibrosis effect of norcantharidin is exerted through inhibition of PP2Ac-mediated C-terminal phosphorylation of Smad3.
Luo HW; Yin DD; Xiao Z; Wen L; Liao YJ; Tang CY; Zeng D; Xiao HT; Li Y
Chem Biol Drug Des; 2021 Feb; 97(2):293-304. PubMed ID: 32896083
[TBL] [Abstract][Full Text] [Related]
20. Theoretical models of catalytic domains of protein phosphatases 1 and 2A with Zn2+ and Mn2+ metal dications and putative bioligands in their catalytic centers.
Woźniak-Celmer E; Ołdziej S; Ciarkowski J
Acta Biochim Pol; 2001; 48(1):35-52. PubMed ID: 11440182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
